Schuppert F, Scheumann G F, Schöber C, Overbeck J, Schürmeyer T H, Schmoll H J, Dralle H, von zur Mühlen A
Klinische Endokrinologie, Medizinische Hochschule Hannover.
Klin Wochenschr. 1991 Dec 11;69(20):937-42. doi: 10.1007/BF01798547.
We present a case report on a 35-year-old patient in whom a malignant sympathetic paraganglioma of the organ of Zuckerkandl was the cause of severe hypertension with excessive perspiration at night. Since curative surgery was not possible medical treatment was initiated. Interferon alfa 2b (Intron A, Essex Pharma) and the somatostatin-analogue SMS 201-995 (Sandostatin, Sandoz) had no effect on catecholamine production and progression of the tumor. Treatment with alpha-methyl-para-tyrosin (MPT, [Metyrosin], Demser, MSD) turned out to be an effective and well tolerable therapy in this patient with peritoneal carcinosis. Clinical and hormonal progression of the paraganglioma resumed only after two years of therapy, which constitutes the longest documented period of time of successful MPT treatment. The superior efficacy of MPT in our patient should encourage postoperative medical treatment with MPT in malignant pheochromocytoma or malignant paraganglioma, particularly when the tumor turns out to be resistent to alpha blocking drugs.
我们报告一例35岁患者,其位于主动脉体的恶性交感神经节旁瘤是导致严重高血压并伴有夜间多汗的原因。由于无法进行根治性手术,遂开始药物治疗。干扰素α-2b(Intron A,埃塞克斯制药公司)和生长抑素类似物SMS 201-995(善得定,山德士公司)对儿茶酚胺生成及肿瘤进展均无作用。α-甲基-对-酪氨酸(MPT,[美替拉酮],德美罗,默克雪兰诺公司)治疗对该患有腹膜癌的患者而言是一种有效且耐受性良好的疗法。仅在治疗两年后副神经节瘤的临床及激素水平进展才再次出现,这是有记录以来MPT成功治疗最长的时间段。MPT在我们这位患者身上的卓越疗效应促使在恶性嗜铬细胞瘤或恶性副神经节瘤术后使用MPT进行药物治疗,尤其是当肿瘤对α受体阻滞剂耐药时。